Mucormycosis in diabetes mellitus

  • Prashant Khatiwada Kathmandu University School of Medical Sciences, Dhulikhel
  • Aditi Giri Kathmandu University School of Medical Sciences, Dhulikhel
  • Prasana Khatiwoda Richa Bajimaya Memorial Foundation, Kathmandu
Keywords: fungal infection, immunodeficiency, mucormycosis

Abstract

Mucormycosis is an opportunistic fulminant fungal infection, which mainly infects immunocompromised patients. Infection with mucormycosis can cause devastating rhino-orbital-cerebral and pulmonary infection with an extremely poor prognosis. The infection begins in the nose and paranasal sinuses due to inhalation of fungal spores. We report a case of mucormycosis in an uncontrolled diabetic patient to emphasize early diagnosis of this potentially fatal fungal infection. Rhino-orbitalcerebral mucormycosis is the most common manifestation in patients with diabetes mellitus. We also review the current concepts in management of mucormycosis. Mucormycosis remains difficult to treat and requires a multifaceted approach involving elimination of predisposing factors, surgical debridement, and anti-fungal therapy. Lipid formulations of Amphotericin B are the treatments of choice.

DOI: http://dx.doi.org/10.3126/jaim.v1i2.6531

Journal of Advances in Internal Medicine 2012;01(02):73-75

Downloads

Download data is not yet available.
Abstract
1329
PDF
473
Published
2012-07-23
How to Cite
Khatiwada, P., Giri, A., & Khatiwoda, P. (2012). Mucormycosis in diabetes mellitus. Journal of Advances in Internal Medicine, 1(2), 73-75. https://doi.org/10.3126/jaim.v1i2.6531
Section
Case Reports